September 22, 2026

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 20% Potential Upside with Robust Revenue Growth

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a prominent player in the biotechnology sector, has captured the attention of investors with its impressive market cap of $9.38 billion and a robust pipeline..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 44% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) stands out in the healthcare sector with its robust approach to tackling central nervous system (CNS) disorders. As a U.S.-based biopharmaceutical company, Supernus is making..

agilon health, inc. (AGL): Investor Outlook Reveals 34% Potential Upside Amidst Mixed Performance Metrics

Agilon Health, Inc. (NYSE: AGL) stands at the intriguing intersection of the healthcare sector and medical care facilities industry, specializing in providing healthcare services for seniors through primary care physicians..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Navigating Growth in Rare Endocrine Diseases

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is making waves in the biotechnology sector, focusing its efforts on discovering and developing innovative therapeutics for rare endocrine diseases and endocrine-related tumors. With a..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring the 94% Potential Upside in a Robust Biotech Portfolio

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering entity in the field of biotechnology, continues to capture the attention of investors with its impressive 94.22% potential upside. As a leading developer..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A Strong Buy with 137.65% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Durham, North Carolina, this biotechnology company is..

Evolent Health, Inc. (EVH) Stock Analysis: Robust Revenue Growth and a 56% Potential Upside Draws Investor Attention

Evolent Health, Inc. (NASDAQ: EVH), a player in the healthcare sector specializing in health information services, is currently drawing investor interest with its notable revenue growth and potential upside. Despite..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 50% Potential Upside in the Biotech Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is capturing the attention of investors with its compelling growth potential in the biotechnology industry. Specializing in novel therapies for rare and orphan diseases, Mirum’s..

Kestra Medical Technologies (KMTS): Investor Outlook with a Strong Potential Upside of 22.27%

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a key player in the medical instruments and supplies industry, has been making waves in the healthcare sector with its innovative approach to cardiovascular..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 50% Potential Upside in Gene-Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneer in the biotechnology sector, stands out as a beacon of innovation in the realm of gene editing. Based in Zug, Switzerland, this company..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 51% Upside Potential Awaits Investors

For investors seeking exposure in the healthcare sector, particularly within the medical devices industry, Establishment Labs Holdings Inc. (NASDAQ: ESTA) presents a compelling opportunity. With a market capitalization of $2.02..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Promising 71% Upside Potential in Biotech

Investors with an eye on the biotechnology sector should turn their attention to Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning force in the healthcare industry. With its current market capitalization..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unpacking a 37.44% Potential Upside

Investors eyeing the healthcare sector might find ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) an intriguing opportunity, especially given its promising potential upside of 37.44%. As a player in the drug manufacturing..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 158.88% Upside in Diagnostics & Research

Opko Health, Inc. (NASDAQ: OPK) is making waves in the healthcare sector, particularly for those investors with an eye on the diagnostics and research industry. With a market capitalization of..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Potential Amidst a 52-Week High

10x Genomics, Inc. (NASDAQ: TXG) is capturing investor attention as the company’s stock sits at the upper end of its 52-week range, recently hitting $79.10. This medical devices firm, based..

Omnicell, Inc. (OMCL) Stock Analysis: Robust Growth Potential with 78% Upside

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, is making waves with an impressive potential upside of 78.41% according to analysts. With a market cap of..

Viridian Therapeutics, Inc. (VRDN): Biotechnology Stock with a 69.72% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has captured the attention of investors in the biotechnology sector with its robust pipeline and substantial growth potential. With a current market capitalization of $2.44..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Diagnostic Sector with a 25.7% Revenue Growth Trajectory

GRAIL, Inc. (NASDAQ: GRAL), a key player in the healthcare sector, is making significant strides with its innovative approach to cancer diagnostics and research. With a market capitalization of $4.82..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating a 26.76% Potential Upside in the Healthcare Sector

Healthcare Services Group, Inc. (NASDAQ: HCSG) presents an intriguing proposition for investors looking to capitalize on the healthcare sector’s growth, particularly within the niche of medical care facilities. With a..

Evotec SE (EVO) Stock Analysis: Exploring a 176% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the dynamic healthcare sector, Evotec SE (EVO) presents a compelling case. Headquartered in Hamburg, Germany, Evotec SE operates as a drug discovery and development company,..

Search

Funds

September 22, 2026

Search

Funds

September 22, 2026

FTSE 100

Funds